Oxford University spin-out OrganOx, the pioneering transplant technology company, has been sold to Japanese medical devices group Terumo in a $1.5 billion (£1.2 billion) deal. The acquisition, one of the largest ever for a UK medical technology business, underscores Britain’s strength in scientific innovation but will